Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for ...
Polycythemia vera (PV ... The goal is to lower your hematocrit level. Hematocrit is the percentage of red blood cells compared with the total amount of blood. You'll get this treatment once ...
Topline data were announced from a phase 3 trial evaluating rusfertide in patients with polycythemia vera (PV ... in 293 PV patients with uncontrolled hematocrit who are phelobotomy-dependent ...
Polycythemia vera (PV ... High numbers for hemoglobin, hematocrit, or blood cell count can all be signs of PV. The CBC takes only a few minutes. Your doctor puts a thin needle into your arm ...
Polycythemia vera is a classic myeloproliferative ... we do is we put patients on a baby aspirin and we try to keep their hematocrit—which is the percentage of blood made up by red blood cells ...
A panelist discusses how they prioritize specific clinical and laboratory parameters when assessing response to first-line ...
Many patients with polycythemia vera, the news release noted ... undergo phlebotomy — described as a process of removing blood to manage elevated levels of hematocrit, or the percentage of red blood ...
The reduction of hematocrit below 45% is a primary treatment ... placebo-controlled trial evaluating rusfertide in 293 patients with polycythemia vera over a 156-week period.
Polycythemia vera is a type of blood cancer ... The other three pre-specified key secondary endpoints, namely hematocrit control and patient-reported outcomes using PROMIS Fatigue SF-8a3 ...
The primary endpoint of the study was met, with a significantly higher proportion of clinical responders 1 among rusfertide-treated patients with PV (77%) compared to those who received placebo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results